FP7
TARGETAMD
Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 66 months
- Total cost
- EUR 7,772,860
- EU contribution
- EUR 5,976,298
- Participants
- 15 from 9 countries
- Topic
- FP7_HEALTH.2012.1.4-4
- Grant agreement
- 305134
Coordinated by Universite de Geneve (CHSwitzerland).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Universite de Geneve | CHSwitzerland | Coordinator | EUR 1,707,274 | known name (0.95) |
| Stadt Wien | ATAustria | Participant | EUR 78,786 | known name (0.95) |
| Bundesinstitut Fur Impfstoffe und Biomedizinische Arzneimittel | DEGermany | Participant | EUR 301,336 | PIC (1.00) |
| Max Delbrueck Centrum Fuer Molekulare Medizin in der Helmholtz-Gemeinschaft (Mdc) | DEGermany | Participant | EUR 282,004 | PIC (1.00) |
| Novartis Pharma GmbH | DEGermany | Participant | Not stated | PIC (1.00) |
| Rheinisch-Westfaelische Technische Hochschule Aachen | DEGermany | Participant | EUR 279,980 | PIC (1.00) |
| Universitaetsklinikum Aachen | DEGermany | Participant | EUR 453,847 | PIC (1.00) |
| 3P Biopharmaceuticals SL | ESSpain | Participant | EUR 297,115 | PIC (1.00) |
| Universidad de Navarra | ESSpain | Participant | EUR 709,162 | PIC (1.00) |
| Centre National de la Recherche Scientifique Cnrs | FRFrance | Participant | EUR 445,412 | known name (0.95) |
| Genosafe Sas | FRFrance | Participant | EUR 291,901 | PIC (1.00) |
| Ud-Genomed Medical Genomic Technologies Kutatas-Fejlesztesi Es Szolgaltato Kft | HUHungary | Participant | EUR 347,380 | PIC (1.00) |
| Igea SpA | ITItaly | Participant | EUR 526,291 | known name (0.95) |
| Amsterdam Biotherapeutics Unit | NLNetherlands | Participant | EUR 233,203 | PIC (1.00) |
| Hotswap Stockholm AB | SESweden | Participant | EUR 22,607 | PIC (1.00) |
Changes of the consortium
First seen on with 15 participants from 9 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.